Figley, Sarah A <br/><br/>
Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury.  [electronic resource] 

 -  PloS one  2014 
 - e96137 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0096137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae<br/>Animals<br/>Female<br/>Genetic Therapy--methods<br/>HEK293 Cells<br/>Humans<br/>Hyperalgesia--etiology<br/>Neovascularization, Physiologic--genetics<br/>Rats<br/>Rats, Wistar<br/>Spinal Cord Injuries--complications<br/>Vascular Endothelial Growth Factor A--biosynthesis<br/>Zinc Fingers